Why choose Mayo Clinic for pancreatic neuroendocrine tumors
Thorvardur Halfdanarson, M.D., Medical Oncologist, Department of Oncology, Mayo Clinic: What I think Mayo has to offer is really being a full service station, if you will, for all things…
Browsing Tag
pancreatic
Aravive to Present Updated Clinical Data from Batiraxcept Trials in Renal and…
HOUSTON, July 28, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic…
Global fecal pancreatic elastase testing market was estimated at a market value of…
Wilmington, Delaware, July 18, 2023 (GLOBE NEWSWIRE) -- According to a deep-dive market assessment by RationalStat, the global fecal pancreatic elastase testing market has been analyzed…
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system…
Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab…
FAK Inhibitor Boosts Anti-PD1 Immunotherapy in Pancreatic Cancer
At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported the…
Purple Biotech Reports Positive Results of CM24 Dose Escalation in Advanced…
Purple’s innovative immuno-oncology, chemotherapy-free regimen reports encouraging Overall Survival data in 3rd line PDAC patientsRandomized Phase 2 study is enrolling as expected with…
ImPact Biotech receives FDA Orphan Drug Designation for Padeliporfin VTP in…
Designation confers advantages including marketing exclusivity and tax credits Padeliporfin VTP Phase 1 trial in Pancreatic cancer to start by end Q4 2023 TEL AVIV, Israel, July 05, 2023…
One-two punch: Novel drug pairing could beat pancreatic cancer
Mutations in the KRAS gene are the major driver of pancreatic cancer. The resulting protein controls multiple signaling pathways involved in cell growth and survival. In cancer, the gene is…
Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food &…
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length…
Theriva Biologics Announces Orphan Drug Designation Granted by the U.S. FDA for…
ROCKVILLE, Md., June 27, 2023 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a clinical-stage company developing therapeutics designed to treat…